Results 291 to 300 of about 2,050,605 (416)

ARE YOUR PRODUCTS SETTING THE PACE? [PDF]

, 1962

openalex   +1 more source

Walking Speed and Risk of Cancer in Two Prospective Cohort Studies. [PDF]

J Cachexia Sarcopenia Muscle
Mak JKL, Tan KCB, Jylhävä J, Hägg S, Cheung CL.   +4 more
europepmc   +1 more source

Chemoresistome mapping in individual breast cancer patients unravels diversity in dynamic transcriptional adaptation

Molecular Oncology, EarlyView.
This study used longitudinal transcriptomics and gene‐pattern classification to uncover patient‐specific mechanisms of chemotherapy resistance in breast cancer. Findings reveal preexisting drug‐tolerant states in primary tumors and diverse gene rewiring patterns across patients, converging on a few dysregulated functional modules. Despite receiving the
Maya Dadiani, Gilgi Friedlander, Gili Perry, Nora Balint‐Lahat, Shlomit Gilad, Dana Morzaev‐Sulzbach, Anjana Shenoy, Noa Bossel Ben‐Moshe, Anya Pavlovsky, Rinat Bernstein‐Molho, Eytan Domany, Iris Barshack, Tamar Geiger, Bella Kaufman, Einav Nili Gal‐Yam   +14 more
wiley   +1 more source

The duration of post-pacing asystole in dogs with atrioventricular block

, 1965
S. Rogel, Herbert Stein
openalex   +1 more source

Slower Pace of Growth in France [PDF]

, 1968

openalex   +1 more source

Channel Estimation for Massive MIMO Systems via Polarized Self-Attention-Aided Channel Estimation Neural Network. [PDF]

Entropy (Basel)
Yang S, Li Y, Liu L, Xia J, Wang B, Li X.   +5 more
europepmc   +1 more source

Tonic signaling of the B‐cell antigen‐specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stages

Molecular Oncology, EarlyView.
B‐cell chronic lymphocytic leukemia (B‐CLL) and monoclonal B‐cell lymphocytosis (MBL) show altered proteomes and phosphoproteomes, analyzed using mass spectrometry, protein microarrays, and western blotting. Identifying 2970 proteins and 316 phosphoproteins, including 55 novel phosphopeptides, we reveal BCR and NF‐kβ/STAT3 signaling in disease ...
Paula Díez, Pablo Juanes‐Velasco, Marina L. García‐Vaquero, Conrad Droste, Alicia Landeira‐Viñuela, Miguel Alcoceba, Helena Fidalgo‐Gómez, Sara Misiego‐Herrero, Almudena Navarro‐Bailón, Mónica Baile, José M. Bastida, Jose Manuel Sanchez‐Santos, Rafael Góngora, Julia Almeida, Marcos Gonzalez‐Diaz, Alberto Orfao, Javier De Las Rivas, Manuel Fuentes   +17 more
wiley   +1 more source

Growth of the Program of All-Inclusive Care for the Elderly and the role of for-profit programs. [PDF]

Health Aff Sch
Miller KEM, Gupta R, Polsky D.
europepmc   +1 more source

Targeted protein degradation in oncology: novel therapeutic opportunity for solid tumours?

Molecular Oncology, EarlyView.
Current anticancer therapies are limited by the occurrence of resistance and undruggability of most proteins. Targeted protein degraders are novel, promising agents that trigger the selective degradation of previously undruggable proteins through the recruitment of the ubiquitin–proteasome machinery. Their mechanism of action raises exciting challenges,
Noé Herbel, Sophie Postel‐Vinay
wiley   +1 more source

β2-microglobulin and cognitive decline: unraveling the mediating role of the Dunedin Pace of Aging methylation. [PDF]

Front Aging Neurosci
Ke Y, Chen P, Wu C, Wang Q, Zeng K, Liang M.   +5 more
europepmc   +1 more source